More affordable drugs offered with health care reform

25 April 2019 - China's health care reform has offered more affordable drugs for patients, said a senior health official ...

Read more →

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?

6 April 2019 - Nearly a quarter of the world’s newly diagnosed cancer cases in 2015 were in China. ...

Read more →

Novartis first-in-class Cosentyx approved in China for psoriasis patients

2 April 2019 - China Health Authority NMPA approved Cosentyx (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are ...

Read more →

VAT cut on ‘orphan drugs’ will lift healthcare burden, but many still struggle to afford medication

24 March 2019 - China has reduced value-added tax (VAT) by 3% on 21 orphan drugs and four active pharmaceutical ingredients ...

Read more →

China pledges stronger reform on approving, monitoring new drugs

23 March 2019 - China pledged to improve its system for registering new drugs in the country this year and ...

Read more →

A tiered health care delivery system for China

22 March 2019 - “China's health-care reform will be regarded as successful when a tiered health-care delivery system is fully ...

Read more →

Think drugs are expensive in the U.S.? Just try China

19 March 2019 - Beijing will want pharma companies to share the pain of the country’s growing health care costs. ...

Read more →

China moves to expand cancer medicine access

6 March 2019 - China's recent policy to increase patients' access to cancer medicines has helped more people receive quality ...

Read more →

China approves first biosimilar of foreign drug, breaking Roche monopoly

27 February 2019 - China’s National Medical Products Administration announced Monday that it has approved the country's first biosimilar drug ...

Read more →

China to establish collaboration network for rare disease diagnosis, treatment

18 February 2019 - China will establish a national collaborative network of hospitals for rare disease diagnosis and treatment to ...

Read more →

China pushes forward reforms to expand access to anti-cancer drugs

13 February 2019 - Life-saving anti-cancer drugs, once hard to afford or find on the market by many patients in ...

Read more →

Pfizer launches China's first pay for performance model for cancer

26 January 2019 - Pfizer launched a pay-for-performance insurance program for its breast cancer drug Ibrance palbociclib in China. The ...

Read more →

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...

Read more →

China unveils pilot "group-buying" plan to cut drug prices

17 January 2019 - China has unveiled a pilot medicine procurement program to be tried in 11 major cities to ...

Read more →

China has a very unhealthy interest in our medical data

14 January 2019 - Chinese companies are required by law to obey directives from Beijing's intelligence agencies. So why would ...

Read more →